Delivery Order SPE2DE24DA017-SPE2D625F0U5H

Award Date 4/1/25
Potential Completion Date 4/4/25
Potential Value $2.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $6,749.16 fixed-price contract with economic price adjustment is for the delivery of a QUADLINK IMPLANT SYSTEM, 10MM. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 6, 2024. Arthrex, a for-profit Subchapter S Corporation, has a significant single-award...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $4,785.00 fixed-price delivery order contract is for the provision of the QUADLINK IMPLANT SYSTEM, 11MM, a specialized orthopedic surgical implant. The contract has an ultimate completion date of October 30, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, is the prime...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $11,754.23 fixed-price delivery order contract is for the supply of the QUADLINK IMPLANT SYSTEM, 9MM, a specialized orthopedic surgical implant. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has been awarded this contract to provide a range of advanced...
This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, is for the supply of a QUADLINK IMPLANT SYSTEM, 11MM to the Defense Logistics Agency's Medical Supply Chain. The fixed-price delivery order contract, valued at $6,161.10, has an ultimate completion date of January 13, 2025. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has been awarded this contract by the Defense Logistics Agency, which...
This is a federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, by the Defense Logistics Agency's Medical Supply Chain. The contract is for the delivery of the QUADLINK IMPLANT SYSTEM, 10MM, a specialized orthopedic medical device, with a ceiling value of $30,132.71. The contract type is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing structure. The contract has an ultimate completion date of April 18, 2025 and...
This is a federal contract award from the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, with a ceiling value of $7,873.80, is for the delivery of QUADLINK IMPLANT SYSTEM, 10MM medical devices. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and has an ultimate completion date of April 11, 2025. This award is not set aside for any specific...
This federal contract award is to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, for the supply of a QUADLINK IMPLANT SYSTEM, 11MM. The contract, valued at $4,533.99, was awarded by the Defense Logistics Agency's Medical Supply Chain (9700|97AS|VPDLATSMED-A) on October 15, 2024 and has a completion date of October 21, 2024. Arthrex is a for-profit Subchapter S Corporation headquartered in Naples, Florida. This contract does not have a set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, valued at $14,967.97, is for the procurement of QUADLINK IMPLANT SYSTEM, 10MM. This is a fixed-price with economic price adjustment contract with a completion date of February 24, 2025. Arthrex is a for-profit Subchapter S Corporation registered in the System for Award Management (SAM) and...
This federal contract award, identified as SPE2DE24DA017|SPE2D625F27N2, was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $34,632.14, is for the delivery of the QUADLINK IMPLANT SYSTEM, 9MM, a specialized orthopedic medical device. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and the ultimate completion date is...
This federal contract award is for the QUADLINK IMPLANT SYSTEM, 10MM, a specialized orthopedic medical product, and was awarded to Arthrex Inc., a global leader in minimally invasive orthopedic technologies. The contract, valued at $8,499.42, is a Delivery Order contract with a Fixed Price with Economic Price Adjustment pricing type. The award was made by the Defense Logistics Agency's Medical Supply Chain, a defense agency, and has an ultimate completion date of January 22, 2025. This...
  • SPE2DE24DA017
    Indefinite Delivery Contract
  • SPE2DE24DA017-SPE2D625F0U5H
    Delivery Order

This federal contract award to Arthrex Inc., a for-profit Subchapter S Corporation, was issued by the Defense Logistics Agency's Medical Supply Chain for the procurement of a QUADLINK IMPLANT SYSTEM, 10MM. The award, valued at $2,865.72, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, identified as SPE2DE24D0020. This $471,048,172.66 IDC runs from June 11, 2024, to September 1, 2029, and allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies through task orders. The contract does not have a set-aside designation, indicating Arthrex's strong competitive position in the federal marketplace. Arthrex is a global leader in minimally invasive orthopedic medical technologies, specializing in developing, manufacturing, and supplying advanced orthopedic products, surgical implants, instruments, and biologics primarily to government healthcare systems, with a focus on serving the VA and DoD.

Generated 7/1/25, 8:14 AM